WHO WE ARE
We envision a world where we can instantly identify any organism on the spot, anywhere in the world.
Founded in 2016 by a team of scientists from the University of Guelph’s Biodiversity Institute of Ontario, Precision Biomonitoring provides TripleLock™ on-site eDNA surveillance platform solutions that give customers earlier detection of organisms for a more rapid response. Customers are any organization that needs on-site surveillance and rapid identification of any organism, in any environment. The Precision Biomonitoring team is at the forefront of technological innovations in the genomics industry.
Our Leadership Team
Mark GoldbergBoard Chair
Dr. Mark Goldberg is a board-certified toxicologist and a serial entrepreneur. He focuses on commercializing innovative technology for a more sustainable world, and mentoring the next generation of entrepreneurs. He holds a PhD in Medicine and earned the Chartered Director designation from the Directors’ College. He serves as Chair of Precision Biomonitoring’s Board of Directors.
John FerraroBoard Director
As a curious, adventure-seeking and bootstrapping visionary, John Ferraro is passionate about agriculture and innovating the food supply chain. He has built organizations and strategic alliances focused on enabling the integration of a sustainable meat proteins supply chain that produces quality food and delivers real value for all, from farmers to end consumers.
John PearsonBoard Director
John Pearson is President and CEO at QDZ Enterprizes Limited and former Global Managing Director of Hatch.
Eric HoskinsBoard Director
Eric is a medical doctor with a PhD in Public Health and Epidemiology from Oxford. An Order of Canada recipient, Eric has worked in health systems in Canada and around the world. He was Ontario’s Minister of Health from 2014-2018, and Minister of Economic Development and Trade from 2013-2014. Most recently, Eric was Chair of the Federal Advisory Council on the Implementation of National Pharmacare, and has been advising the private sector on COVID-19 since the pandemic began. Eric brings his knowledge of health care and innovation to his role as Board director.
Mario ThomasCo-founder, board director, & CEO
A visionary leader and serial entrepreneur with 35 years of international experience creating, leading, and growing biotech start-ups to deliver value to stakeholders.
David BoltonCHIEF FINANCIAL OFFICER
A builder of finance team capabilities, David focuses on structuring the organization to effectively scale and exploit growth opportunities.
Vanessa WilliamsonVICE PRESIDENT, NEW OPPORTUNITIES
Vanessa has more than 20 years experience evaluating emerging technology opportunities and bringing them to market, with focus in the life sciences and tech sectors.
Jeff CampbellVICE PRESIDENT, CORPORATE DEVELOPMENT
Jeff understands how to build businesses and commercialize technology in B2B markets globally. His sales, marketing, and go-to-market strategic acumen have been proven over 37 years of success.
Chris StoneVice president, Operations
Over 20 years of experience leading manufacturing and operations in a regulated environment.
At PBI, we deliver gold-standard eDNA surveys that provide the fastest and most accurate results in the industry. At all times, we are at the forefront of technological innovation in DNA testing. We are resourceful and creative, and are committed to over delivering on client expectations.
We are working at the forefront of eDNA technologies, using innovative tools and techniques to produce results.
We are solving the toughest industry-wide challenges.
We form long-lasting relationships with our valued customers.
We produce reliable, transparent results you can trust.
We develop the most accurate tests through rigorous laboratory and third-party validation.
We are dedicated to what we do. From assay development to field validations, every step is done carefully and passionately.
Think our platform could be adapted to your business? Fill out the form below and a PBI team member will be in touch!